No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Tien Liang BioTech Co., Ltd., established in 1960 and headquartered in New Taipei City, Taiwan, is a pharmaceutical enterprise involved in the development, manufacturing, and global distribution of a diverse array of health and medicinal products. The company's offerings include traditional Chinese medicine (TCM) formulations, predominantly in pill form. These remedies address a broad spectrum of conditions, such as internal organ deficiencies (e.g., liver and kidney), various forms of musculoskeletal and neuropathic discomfort (including low back pain, joint pain, rheumatism, gout, and neuralgia), and common ailments like dizziness, digestive issues (constipation, hemorrhoids), respiratory symptoms (colds, bronchitis, coughs), and skin conditions (athlete's foot). Additionally, Tien Liang BioTech provides a range of Western pharmaceutical products. This segment features topical applications like ointments, pain relief gels, soreness sprays, and transdermal pain patches, alongside oral preparations such as tablets and capsules. The portfolio also includes specialized items like hair removal creams. Beyond pharmaceuticals, the company extends its reach into general consumer health and personal care. These offerings comprise products designed for body relaxation and comfort, items to alleviate post-exercise discomfort, oral hygiene products, and various soaps.
www.tlb.com.twNo one on the platform currently holds 4127.TWO.
No tracked institution reports a position in 4127.TWO as of their last filing.
No one on the platform has traded 4127.TWO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 4127.TWOTien Liang BioTech Co., Ltd. | $59.60 | -0.33% | $2.7B | — |
| 1780.TWOAllied Biotech Corporation | $25.15 | +2.65% | $2.7B | — |
| 4160.TWOGenetics Generation Advancement Corp. | $39.05 | +0.39% | $1.0B | — |
| 4161.TWOBioptik Technology Incorporation | $22.25 | +0.00% | $1.3B | — |
| 6496.TWOExcelsior Biopharma Inc. | $24.45 | -0.81% | $1.1B | — |
| 6539.TWODV Biomed Co., Ltd. | $40.65 | +0.25% | $990M | — |
| 6564.TWOEnimmune corporation | $16.95 | +0.89% | $1.2B | — |
Source: Financial Modeling Prep · peers by sector/industry